Investor Relations >> Introduction

Investor Relations Introduction

We value feedback and recommendations from individuals and institutions who own our shares

We recommend that shareholders register to receive the latest news and press releases by email.  

Please click here to send us an immediate request for information

Please click here to sign up for Synergy email alerts

We are also pleased to receive your inquiries via post, email, fax or phone to: 

Email:  info@synergypharma.com

Fax:      [+1] 212-297-0019

Phone:  [+1] 212-297-0020

Address:

  1. Synergy Pharmaceuticals, Inc.

  2. 420 Lexington Avenue, Suite 1609

  3. New York, NY 10170

  4. USA

Investor Relationsshapeimage_8_link_0
SEC FilingSEC_Filings.htmlshapeimage_9_link_0
Information RequestInformation_Request.htmlshapeimage_10_link_0
Stock InformationStock_Information.htmlshapeimage_11_link_0
About UsAbout_Synergy_Pharmaceuticals.htmlshapeimage_12_link_0
PipelinePipeline_Overview.htmlshapeimage_13_link_0
PartneringPartnering.htmlshapeimage_14_link_0
Investor Relationsshapeimage_15_link_0
NewsSynergy_News_Summary.htmlshapeimage_16_link_0
Contact UsContact_Us.htmlshapeimage_17_link_0
Legal | Contact UsLegal.htmlContact_Us.htmlshapeimage_20_link_0shapeimage_20_link_1
Corporate GovernanceCorporate_Governance.htmlshapeimage_22_link_0
Sign Up to Receive E-mail AlertsSign_Up_to_Receive_E-mail_Alerts.htmlshapeimage_23_link_0
Press ReleasesSynergy_News_Summary.htmlshapeimage_24_link_0